T cell
jhalper | September 12, 2011Last month, Penn Medicine put out a press release heralding a "cancer treatment breakthrough 20 years in the making." In a small clinical trial, three patients with advanced chronic lymphocytic leukemia (CLL) were treated with genetically engineered versions of their own T cells. Just a few weeks after treatment the tumors had disappeared, and the patients remained in remission for a year before the study was published.
The release didn't, however, explain those "20 years in the making." In 1989, Prof. Zelig Eshhar of the Weizmann Institute's Immunology Department first published a paper…
jhalper | July 23, 2011Today's science news from the Weizmann Institute covers research in neurobiology, environmental science and cancer immunology.
⢠In the first, scientists identified a likely biological marker for autism that shows up even in very young children. Diagnoses of autism are generally not possible so early, as the signs typically appear gradually throughout the first 3-4 years of life. The scientists used fMRI to scan the brains of children aged 1-3 who were just starting to show signs of autistic behavior. Their method: scanning the brains of toddlers while they sleep. It seems that even asleep…